Suppr超能文献

雌激素调节剂在男性性腺功能减退和不育症中的作用

The Role of Estrogen Modulators in Male Hypogonadism and Infertility.

作者信息

Rambhatla Amarnath, Mills Jesse N, Rajfer Jacob

机构信息

Department of Urology, David Geffen School of Medicine at UCLA Los Angeles, CA.

出版信息

Rev Urol. 2016;18(2):66-72. doi: 10.3909/riu0711.

Abstract

Estradiol, normally considered a female hormone, appears to play a significant role in men in a variety of physiologic functions, such as bone metabolism, cardiovascular health, and testicular function. As such, estradiol has been targeted by male reproductive and sexual medicine specialists to help treat conditions such as infertility and hypogonadism. The compounds that modulate estradiol levels in these clinical conditions are referred to as selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs). In a certain subset of infertile men, particularly those with hypogonadism, or those who have a low serum testosterone to estradiol ratio, there is some evidence suggesting that SERMs and AIs can reverse the low serum testosterone levels or the testosterone to estradiol imbalance and occasionally improve any associated infertile or subfertile state. This review focuses on the role these SERMs and AIs play in the aforementioned reproductive conditions.

摘要

雌二醇通常被认为是一种女性激素,但它似乎在男性的多种生理功能中发挥着重要作用,如骨骼代谢、心血管健康和睾丸功能。因此,男性生殖与性医学专家将雌二醇作为治疗不育症和性腺功能减退等病症的靶点。在这些临床病症中调节雌二醇水平的化合物被称为选择性雌激素受体调节剂(SERM)和芳香化酶抑制剂(AI)。在一部分不育男性中,尤其是那些患有性腺功能减退症的男性,或者血清睾酮与雌二醇比值较低的男性,有证据表明SERM和AI可以逆转血清睾酮水平低下或睾酮与雌二醇失衡的状况,偶尔还能改善任何相关的不育或亚不育状态。本综述重点关注这些SERM和AI在上述生殖病症中所起的作用。

相似文献

2
5
Clinical Use of Aromatase Inhibitors in Adult Males.芳香化酶抑制剂在成年男性中的临床应用
Sex Med Rev. 2014 Apr;2(2):79-90. doi: 10.1002/smrj.23. Epub 2015 Oct 19.
7
Testosterone replacement in the infertile man.不育男性的睾酮替代治疗。
Transl Androl Urol. 2016 Dec;5(6):859-865. doi: 10.21037/tau.2016.08.03.

引用本文的文献

本文引用的文献

3
The neuroprotective actions of oestradiol and oestrogen receptors.雌激素及其受体的神经保护作用。
Nat Rev Neurosci. 2015 Jan;16(1):17-29. doi: 10.1038/nrn3856. Epub 2014 Nov 26.
6
An overview of current and emerging SERMs.当前及新型选择性雌激素受体调节剂概述
J Steroid Biochem Mol Biol. 2014 Sep;143:207-22. doi: 10.1016/j.jsbmb.2014.03.003. Epub 2014 Mar 22.
7
Anabolic steroid-induced hypogonadism: diagnosis and treatment.合成代谢类固醇所致性腺功能减退症:诊断与治疗。
Fertil Steril. 2014 May;101(5):1271-9. doi: 10.1016/j.fertnstert.2014.02.002. Epub 2014 Mar 14.
10
Risks and benefits of testosterone therapy in older men.老年男性睾酮治疗的风险和益处。
Nat Rev Endocrinol. 2013 Jul;9(7):414-24. doi: 10.1038/nrendo.2013.73. Epub 2013 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验